Pay in 4 interest-free payments of $5.04 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Volkow, Nathan A
Beyond the financial implications, counterfeit or improperly handled therapies create significant patient safety risks - particularly when temperature-related degradation leaves no visible indication of compromised efficacy
Consult current peer-reviewed literature, clinical-trial records, official regulatory information, and qualified professionals.
The eyes, lungs and heart may also be targeted
LBA 25 Fung, J
This figure will increase to 5.6 million by 2030
US$ 24.34
US$ 22.06
US$ 23.80
US$ 21.82
US$ 27.86
